Skip to content
healthcare.dev

Oxcarbazepine

NDC 62135-841, Oxcarbazepine, suspension, from Chartwell RX, LLC.

Product NDC
62135-841
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212428
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-841 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE300 mg/5mL

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
62135-841-246213508412420 CUP, UNIT-DOSE in 1 CARTON (62135-841-24) / 5 mL in 1 CUP, UNIT-DOSE (62135-841-45)
62135-841-5462135084154250 mL in 1 BOTTLE (62135-841-54)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c2affa00-1d57-4d85-8db3-745191b4714d
  • NADAC price for package 62135084154

    GET /v1/drugs/nadac/62135084154

Use it

Look up 62135-841 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-841 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-841. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.